“…Our meta-analysis showed elevated serum 5-HT levels following TMS, with null or mixed findings across NIBS and biomarker sampling methods. Indeed, clinical and preclinical studies that assessed the effects of TMS [ 62 , 63 , 64 , 65 , 68 , 69 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 ] and ECT [ 44 , 57 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 ] on 5-HT concentrations reported mostly heterogenous results, with 61% of comparisons reporting null effects ( Figure 4 a,b), with similar mixed results when examining effects by biomarker source ( Figure 5 a–f). ECT did not have a significant effect on 5-HT levels, suggesting that the therapeutic mechanisms of ECT differ from rTMS.…”